Date published:
Audience:
General public
The University of New South Wales will receive funding under the MRFF’s National Critical Research Infrastructure initiative to:
- establish a platform that can screen newborns for illnesses such as biotinidase deficiency, haemophilia, cystic fibrosis, spinal muscular atrophy and severe combined immunodeficiency
- undertake a 12-month research trial of the platform in Queensland.
Read the media release for more information.
Learn about the MRFF.